Status:
COMPLETED
Innovative Approach to Reduce Lung Cancer Stigma
Lead Sponsor:
University of Arizona
Conditions:
Lung Cancer Stigma
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a feasibility study examining the feasibility and acceptability of a novel psychotherapy intervention on lung cancer patients who are experiencing stigma.
Detailed Description
Experiences of stigma (perception and internalization of negative appraisal and devaluation from others) are pervasive for lung cancer patients. Previous work has shown associations between lung cance...
Eligibility Criteria
Inclusion
- Proficiency in English
- Diagnosed with or treated for Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) within the prior 12 months.
- Scores of 37.5 on the Lung Cancer Stigma Inventory (LCSI) screening measure
Exclusion
- Not proficient in English
Key Trial Info
Start Date :
October 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 13 2020
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03750864
Start Date
October 27 2018
End Date
July 13 2020
Last Update
July 28 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona Cancer Center
Tucson, Arizona, United States, 85724
2
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065